KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Ratio (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Equity Ratio for 16 consecutive years, with 0.49 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Equity Ratio rose 4.44% year-over-year to 0.49, compared with a TTM value of 0.49 through Sep 2024, up 4.44%, and an annual FY2023 reading of 0.47, up 4.42% over the prior year.
  • Equity Ratio was 0.49 for Q3 2024 at Thermo Fisher Scientific, up from 0.48 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.55 in Q3 2021 and bottomed at 0.43 in Q4 2021.
  • Average Equity Ratio over 5 years is 0.48, with a median of 0.48 recorded in 2024.
  • The sharpest move saw Equity Ratio increased 12.38% in 2021, then decreased 16.85% in 2022.
  • Year by year, Equity Ratio stood at 0.5 in 2020, then decreased by 14.08% to 0.43 in 2021, then increased by 5.52% to 0.45 in 2022, then grew by 4.42% to 0.47 in 2023, then rose by 3.1% to 0.49 in 2024.
  • Business Quant data shows Equity Ratio for TMO at 0.49 in Q3 2024, 0.48 in Q2 2024, and 0.47 in Q1 2024.